We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current LPTX market cap is 81.04M. The company's latest EPS is USD -3.1845 and P/E is -1.00.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -15.29M | -13.94M | -42.73M | -14.66M | -14.83M |
| Net Income | -15.09M | -12.1M | -41.86M | -13.39M | -13.7M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 1.5M | 1.5M | 0 | 0 |
| Operating Income | -33.45M | -28.54M | -41.43M | -56.76M | -87.04M |
| Net Income | -33.26M | -37.59M | -40.59M | -54.6M | -81.41M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 82.17M | 70.35M | 106.55M | 95.86M | 83.05M |
| Total Liabilities | 12.09M | 11.49M | 10.5M | 11.8M | 11.04M |
| Total Equity | 70.07M | 58.87M | 28.33M | 84.06M | 72.01M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 7.45M | 54.37M | 117.91M | 70.35M | 72.83M |
| Total Liabilities | 9.2M | 7.72M | 10.02M | 11.49M | 12.68M |
| Total Equity | -1.75M | 46.65M | 107.89M | 58.87M | 60.14M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -36.03M | -49.04M | -12.7M | -22.89M | -33.37M |
| Investing | N/A | N/A | 49.32M | 48.97M | 48.97M |
| Financing | -210k | -210k | -29k | -29k | -30k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -26.9M | -25.96M | -35.16M | -49.04M | -43.75M |
| Investing | -85k | 25k | N/A | N/A | 48.97M |
| Financing | 14.82M | 74M | 98.04M | -210k | -30k |
| Market Cap | 81.04M |
| Price to Earnings Ratio | -1.00 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.15 |
| Price to Book Ratio | 1.35 |
| Dividend Yield | - |
| Shares Outstanding | 25.57M |
| Average Volume (1 week) | 186.25k |
| Average Volume (1 Month) | 554.2k |
| 52 Week Change | -11.94% |
| 52 Week High | 10.20 |
| 52 Week Low | 1.235 |
| Spread (Intraday) | 0.1 (3.04%) |
| Company Name | Leap Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.leaptx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
